274 related articles for article (PubMed ID: 19345526)
21. Vascular calcification in chronic kidney disease: mechanisms and clinical implications.
Ossareh S
Iran J Kidney Dis; 2011 Sep; 5(5):285-99. PubMed ID: 21876304
[TBL] [Abstract][Full Text] [Related]
22. [Disturbances of mineral metabolism and vascular calcifications in dialysis patients (review)].
Malberti F; Ravani P
G Ital Nefrol; 2004; 21(3):238-44. PubMed ID: 15285002
[TBL] [Abstract][Full Text] [Related]
23. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
24. [Update on the pathogenesis and possible therapeutic approach to vascular calcifications in patients with chronic renal failure].
Pasquali M; Tartaglione L; Rotondi S; Muci ML; Pirro' G; Mazzaferro S
G Ital Nefrol; 2011; 28(5):514-24. PubMed ID: 22028265
[TBL] [Abstract][Full Text] [Related]
25. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein.
Proudfoot D; Shanahan CM
Nephrology (Carlton); 2006 Oct; 11(5):455-61. PubMed ID: 17014561
[TBL] [Abstract][Full Text] [Related]
27. [Cardiovascular risk in women with chronic renal failure: mammographic study of vascular calcifications].
Canabal A; Sabate J; Salgueira M; Palma A
Radiologia; 2008; 50(1):54-60. PubMed ID: 18275790
[TBL] [Abstract][Full Text] [Related]
28. The role of magnesium binders in chronic kidney disease.
Spiegel DM
Semin Dial; 2007; 20(4):333-6. PubMed ID: 17635824
[TBL] [Abstract][Full Text] [Related]
29. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis.
Raggi P; Giachelli C; Bellasi A
Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):26-33. PubMed ID: 17180147
[TBL] [Abstract][Full Text] [Related]
30. [The effects of changes in phosphocalcic metabolism in ocular tissues in patients with chronic hemodialysis].
Ciocâlteu AM
Oftalmologia; 2008; 52(1):18-21. PubMed ID: 18714485
[TBL] [Abstract][Full Text] [Related]
31. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review.
McCullough PA; Sandberg KR; Dumler F; Yanez JE
J Nephrol; 2004; 17(2):205-15. PubMed ID: 15293519
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous calcification in patients with end-stage renal disease: a regulated process associated with in situ osteopontin expression.
Rivet J; Lebbé C; Urena P; Cordoliani F; Martinez F; Baglin AC; Aubert P; Aractingi S; Ronco P; Fournier P; Janin A
Arch Dermatol; 2006 Jul; 142(7):900-6. PubMed ID: 16847207
[TBL] [Abstract][Full Text] [Related]
33. Vascular calcification in chronic kidney disease: a changing scenario.
Cozzolino M; Brenna I; Ciceri P; Volpi E; Cusi D; Brancaccio D
J Nephrol; 2011; 24 Suppl 18():S3-10. PubMed ID: 21623576
[TBL] [Abstract][Full Text] [Related]
34. Regulatory mechanisms in vascular calcification.
Boström K; Demer LL
Crit Rev Eukaryot Gene Expr; 2000; 10(2):151-8. PubMed ID: 11186330
[TBL] [Abstract][Full Text] [Related]
35. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes.
Cannata-Andía JB; Rodríguez-García M; Carrillo-López N; Naves-Díaz M; Díaz-López B
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S267-73. PubMed ID: 17130273
[TBL] [Abstract][Full Text] [Related]
36. Consequences of chronic kidney disease--mineral and bone disorder: a progressive disease.
Smith KR; Smelt SC
Nephrol Nurs J; 2009; 36(1):49-55. PubMed ID: 19271624
[TBL] [Abstract][Full Text] [Related]
37. [From kidney disease to ischemic heart disease].
Strada E; Savazzi G
Recenti Prog Med; 2011 Apr; 102(4):166-71. PubMed ID: 21572494
[TBL] [Abstract][Full Text] [Related]
38. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.
Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P
Adv Clin Chem; 2008; 46():217-62. PubMed ID: 19004191
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of hemodialysis patients with intimal versus medial vascular calcifications.
Damjanovic T; Djuric S; Schlieper G; Markovic N; Dimkovic S; Radojicic Z; Krüger T; Floege J; Dimkovic N
J Nephrol; 2009; 22(3):358-66. PubMed ID: 19557712
[TBL] [Abstract][Full Text] [Related]
40. Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia.
Graciolli FG; Neves KR; dos Reis LM; Graciolli RG; Noronha IL; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2009 May; 24(5):1416-21. PubMed ID: 19075196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
